MedTrace Logo

Undiagnosed Hepatitis C Infection in an Urban Hospital

NCT01957085 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 366

Last updated 2020-04-24

Study results available
· View outcomes & findings →

Summary

The Centers for Disease Control and Prevention estimates that there are approximately 3.2 million people in the United States infected with hepatitis C and a significant percentage of these patients are unaware of their diagnosis. This study will attempt to determine the point prevalence of undiagnosed hepatitis C infection in an urban hospital population. All patients admitted to the hospital on two separate days will have hepatitis C testing done on leftover serum and plasma that was collected as part of routine inpatient lab work. Our primary goal is to determine the number of undiagnosed hepatitis C infected patients in our hospitalized population. We will also compare these rates to specific demographic characteristics, such as age, race, gender, zip code and type of insurance to see if any associations exist between these demographics and undiagnosed hepatitis C infection.

Conditions

  • Hepatitis C

Interventions

OTHER

observation only

This is an observational only, nonintervention study. There will be no patient contact. This was a de-identified point prevalence study of hepatitis C infection in hospitalized patients in an inner city hospital.

Sponsors & Collaborators

  • Janssen Services, LLC

    collaborator INDUSTRY

  • Temple University

    lead OTHER

Principal Investigators

  • Robert Bettiker, MD · Temple University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2015-12-31
Completion
2016-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01957085 on ClinicalTrials.gov